Searching For Real Value In Market Debris At uniQure N.V. (NASDAQ: QURE)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted uniQure Announces Update on Phase I/II Clinical Trials of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

As a NASDAQ listed company, QURE falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of uniQure N.V. is $305.03M. A total of 0.91 million shares were traded on the day, compared to an average of 1.10M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, QURE has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 9 BUYs and 36 SELLs from insiders. Insiders purchased 116,700 shares during that period but sold 109,059.

In the most recent transaction, Dolmetsch Ricardo sold 5,841 shares of QURE for 7.46 per share on Sep 18. After the transaction, the President, R&D now owns 163,404 company shares. In a previous transaction on Jul 10, CALOZ PIERRE sold 15,117 shares at 11.36 per share. QURE shares that Chief Operating Officer owns now total 95,098.

Among the insiders who sold shares, Gut Robert disposed of 3,228 shares on Jun 16 at a per-share price of $18.88. This resulted in the Director holding 47,669 shares of QURE after the transaction. In another insider transaction, CALOZ PIERRE sold 2,920 shares at $18.80 per share on Jun 16. Company shares held by the Chief Operating Officer now total 110,215.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for QURE in the last 3 months, the mean price target is $29.42 with high estimates of $63.00 and low estimates of $10.00. In terms of 52-week highs and lows, QURE has a high of $22.48 and a low of $5.19.

As of this writing, QURE has an earnings estimate of -$1.45 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of -$0.61 per share and a lower estimate of -$1.89. The company reported an EPS of -$1.44 in the last quarter, which was -170.20% lower than expectations of $2.05.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. QURE’s latest balance sheet shows that the firm has $556.26M in Cash & Short Term Investments as of fiscal 2021. There were $135.72M in debt and $36.76M in liabilities at the time. Its Book Value Per Share was $5.62, while its Total Shareholder’s Equity was $595.78M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for QURE is Buy with a score of 4.57.

Most Popular

Related Posts